Evidence map›Paper›PMID 40547454›Full record

ArticleComputational and structural biotechnology journal2025

MFE-DDI: A multi-view feature encoding framework for drug-drug interaction prediction.

Lingfeng Wang, Yinghong Li, Yaozheng Zhou, Liping Guo, Congzhou Chen

Abstract read
In one paragraph

Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. KG-DFI: A Prediction of Drug-Food Interactions Based on Knowledge Graph Embedding.Computational and structural biotechnology journal · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lingfeng WangBeijing University of Chemical Technology, Beijing, 100029, China.
Yinghong LiBeijing University of Chemical Technology, Beijing, 100029, China.
Yaozheng ZhouBeijing University of Chemical Technology, Beijing, 100029, China.
Liping GuoChina Japan Friendship Hospital, Beijing, 100029, China.
Congzhou ChenBeijing University of Chemical Technology, Beijing, 100029, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multidrug combination therapy has long been a vital approach for treating complex diseases by leveraging synergistic effects between drugs. However, drug-drug interactions (DDIs) are not uniformly beneficial. Accurate and rapid identification of DDIs is critical to mitigate drug-related side effects. Currently, many computational-based methods have been used to expedite the prediction of DDIs. However, most of these methods use a single perspective to obtain drug features, which have limited expressive capabilities and cannot fully represent the essential attributes of drugs. In this study, we propose the Multi-view Feature Embedding for drug-drug interaction prediction (MFE-DDI), which integrates SMILES information, molecular graph data and atom spatial semantic information to model drugs from multiple perspectives and encapsulate the intricate drug information crucial for predicting DDIs. Concurrently, the feature information extracted from different feature encoding channels is fused in the attention-based fusion module to fully convey the essence of drugs. Consequently, this approach enhances the efficacy of the DDI prediction task. Experimental results indicate that MFE-DDI surpasses other baseline methods on three datasets. Moreover, analysis experiments demonstrate the robustness of the model and the necessity of each component of the model. Case studies on newly approved drugs demonstrate the effectiveness of our method in real scenarios. The code and data used in MFE-DDI can be found at https://github.com/2019040445/MFE_DDI.

Indexed as

Deep learningDrug interactionMultidimensional feature fusionMulti-view drug features

Identifiers

PMID40547454
PMCPMC12181007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.